AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Curbing the Opioid Crisis: The Role of the Clinical Laboratory for Pain Management

  • Credit:1.0 ACCENT Credits
  • Duration: 1 Hour
  • Date:MAY.20.2020 1:00 PM - 02:00 PM

Price: $0.00

Member Price: $0.00

If you have previously registered for this webinar, you can go directly to the On Demand page.


On average, 130 Americans die every day from an overdose of opioids, the class of drugs that includes heroin, hydrocodone, codeine, morphine and fentanyl. Drug overdose is now the leading cause of accidental death in the United States. In this webinar, you will learn why your clinical laboratory is critically important in helping clinicians care for patients struggling with drug abuse. You will also learn about the advantages of using a specific urine drug screening technology that eliminates cross-reactivities with other drugs. Additionally, advantages of using oral fluid samples will be presented.


  • A description of the history and depth of the Opioid Crisis.
  • How to explain the importance of the clinical laboratory in the patient continuum.
  • To list the advantages of using a specific urine drug screening technology to eliminate cross-reactivity with other drugs.
  • How to describe the advantages of oral fluid drug testing.
  • How to describe the role of LC-MS for confirmation testing of urine and oral fluids.


Dr. Alan Wu photoAlan H. B. Wu, PhD, DABCC, FAACC
Director of Clinical Chemistry and Toxicology
Department of Laboratory Medicine
University of California, San Francisco
San Francisco, CA USA


This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 1990. This activity was planned in accordance with ACCENT® Standards and Policies.

Supported By

Thermo Fisher logo